Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Redirection to the bone marrow improves T cell persistence and antitumor functions
Anjum B. Khan, … , Cristina Lo Celso, Ronjon Chakraverty
Anjum B. Khan, … , Cristina Lo Celso, Ronjon Chakraverty
Published February 27, 2018
Citation Information: J Clin Invest. 2018;128(5):2010-2024. https://doi.org/10.1172/JCI97454.
View: Text | PDF
Research Article Immunology

Redirection to the bone marrow improves T cell persistence and antitumor functions

  • Text
  • PDF
Abstract

A key predictor for the success of gene-modified T cell therapies for cancer is the persistence of transferred cells in the patient. The propensity of less differentiated memory T cells to expand and survive efficiently has therefore made them attractive candidates for clinical application. We hypothesized that redirecting T cells to specialized niches in the BM that support memory differentiation would confer increased therapeutic efficacy. We show that overexpression of chemokine receptor CXCR4 in CD8+ T cells (TCXCR4) enhanced their migration toward vascular-associated CXCL12+ cells in the BM and increased their local engraftment. Increased access of TCXCR4 to the BM microenvironment induced IL-15–dependent homeostatic expansion and promoted the differentiation of memory precursor–like cells with low expression of programmed death-1, resistance to apoptosis, and a heightened capacity to generate polyfunctional cytokine-producing effector cells. Following transfer to lymphoma-bearing mice, TCXCR4 showed a greater capacity for effector expansion and better tumor protection, the latter being independent of changes in trafficking to the tumor bed or local out-competition of regulatory T cells. Thus, redirected homing of T cells to the BM confers increased memory differentiation and antitumor immunity, suggesting an innovative solution to increase the persistence and functions of therapeutic T cells.

Authors

Anjum B. Khan, Ben Carpenter, Pedro Santos e Sousa, Constandina Pospori, Reema Khorshed, James Griffin, Pedro Velica, Mathias Zech, Sara Ghorashian, Calum Forrest, Sharyn Thomas, Sara Gonzalez Anton, Maryam Ahmadi, Angelika Holler, Barry Flutter, Zaida Ramirez-Ortiz, Terry K. Means, Clare L. Bennett, Hans Stauss, Emma Morris, Cristina Lo Celso, Ronjon Chakraverty

×

Figure 1

Adoptively transferred TCXCR4 demonstrate superior recruitment to the BM.

Options: View larger image (or click on image) Download as PowerPoint
Adoptively transferred TCXCR4 demonstrate superior recruitment to the BM...
(A) Representative flow cytometry plots for CXCR4 expression in untreated CD8+ T cells (unstimulated), TControl, or TCXCR4. Gating based on “fluorescence minus 1” controls. CXCR4 median fluorescence index (MFI): 380 unstimulated; 587 GFP+ TControl; 2,409 GFP+ TCXCR4. (B and C) Equal mixtures of TCXCR4 (CD45.1+) and TControl (Thy1.1+) were injected into sublethally irradiated B6 mice. Representative plots of TCXCR4 (red) and TControl (blue) frequencies in BM, spleen (Sp), and LN at day 7 are shown in B. Summary graphs in C indicate mean ± SD TCXCR4/TControl ratio at timed intervals in BM, Sp, and LN (n = 6 per group at 3 and 24 hours, n = 4 per group at day 7). Statistical comparison was performed by Wilcoxon’s signed-rank test against a hypothetical ratio of 1.0 (dotted line). *P ≤ 0.05. (D) Box-and-whisker graphs for BM/LN ratio on day 14 following transfer of TCXCR4 or TControl to separate sublethally irradiated B6 mice, calculated by division of percent GFP+ of BM CD8+ T cells by percent GFP+ of LN CD8+ T cells (n = 6 TCXCR4, n = 5 TControl). (E) Box-and-whisker graphs of TCXCR4/TControl ratio in BM, Sp, and LN at day 7 following transfer into sublethally irradiated B6 mice (n = 4) and untreated Rag1ko mice (n = 10). (F) Box-and-whisker graphs of TCXCR4/TControl ratio in BM, Sp, and LN at day 7 following transfer into untreated B6 mice (n = 11) and untreated Rag1ko mice (n = 10). (G) Box-and-whisker graphs of ratio of TCXCR4/TControl in BM, Sp, and LN at day 7 following transfer into Rag1ko (n = 10), Rag1ko.Il15rako (n = 10), and Rag1ko.Il7ko (n = 4). Statistical comparisons in D and E were made using the Mann-Whitney test (2-tailed). *P ≤ 0.05, **P ≤ 0.01. All data are pooled from 2–3 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts